Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 6
1971 1
1972 4
1973 4
1974 6
1975 5
1976 3
1977 4
1978 8
1979 3
1980 3
1982 4
1983 3
1984 1
1986 4
1987 1
1991 1
1993 2
1994 2
1998 2
2009 2
2012 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study.
Marberger M Jr, Altwein JE, Orestano F. Marberger M Jr, et al. Invest Urol. 1976 Jan;13(4):302-6. Invest Urol. 1976. PMID: 1245393
To investigate the effect of gestagens on renal cell carcinoma 300-mg slices of normal, human kidney, renal cell carcinoma (RCC), and preoperatively irradiated RCC were subjected to a short term incubation with 200 pmoles of 3H-testosterone and 1 and 2 mug of gestonorone
To investigate the effect of gestagens on renal cell carcinoma 300-mg slices of normal, human kidney, renal cell carcinoma (RCC), and preope …
[Gestonorone therapy of prostatic adenoma].
Lopatkin N, Darenkow A, Sahmatow J, Tankó A, Ignaschin N, Warentsow G. Lopatkin N, et al. Acta Chir Acad Sci Hung. 1980;21(4):271-8. Acta Chir Acad Sci Hung. 1980. PMID: 6175122 Clinical Trial. German.
Clinical trials with gestonorone led to favourable results in 65% of the patients. The drug is recommended particularly to patients in stage I or II of prostatic adenoma. ...
Clinical trials with gestonorone led to favourable results in 65% of the patients. The drug is recommended particularly to patients i …
Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk.
Li W, Klein RJ. Li W, et al. Prostate Cancer Prostatic Dis. 2021 Jun;24(2):492-498. doi: 10.1038/s41391-020-00303-2. Epub 2020 Nov 20. Prostate Cancer Prostatic Dis. 2021. PMID: 33219367
We validated four significant variants located at four different loci in validation cohort: rs8027714 at 15q11.2, rs8136152 at 22q13.2, rs10192133 at 2q24.2, and rs1237696 at 11q22.1. rs1237696 is an intronic variant on chromosome 11 in the progesterone receptor (PGR) gene (P = 4 …
We validated four significant variants located at four different loci in validation cohort: rs8027714 at 15q11.2, rs8136152 at 22q13.2, rs10 …
Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate.
Orestano F, Altwein JE. Orestano F, et al. Br J Urol. 1976 Dec;48(6):485-91. doi: 10.1111/j.1464-410x.1976.tb06687.x. Br J Urol. 1976. PMID: 64267 Clinical Trial.
18 patients with obstructive benign prostatic hypertrophy were studied. A 5-day treatment with gestonorone caproate (200 mg daily and 200 mg on alternate days) and cyproterone acetate (300 mg daily) suppressed the plasma LH and serum LH levels. ...The uptake of tota …
18 patients with obstructive benign prostatic hypertrophy were studied. A 5-day treatment with gestonorone caproate (200 mg da …
Influence of gestonorone caproate on rat prostate.
Hayashi T, Glotz HJ, Aono T, Matsumoto K. Hayashi T, et al. J Steroid Biochem. 1979 Sep;11(3):1217-21. doi: 10.1016/0022-4731(79)90187-0. J Steroid Biochem. 1979. PMID: 513741 No abstract available.
73 results